Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye.
Multidrug-resistant cells contain a plasma membrane efflux pump, the multidrug transporter, which actively expels certain hydrophobic drugs from the cytosol to the cell exterior. These drugs are usually positively charged at physiological pH. Because one might predict that this efflux of positively charged molecules might deplete the cytosol of protons, raising the cytosolic pH, we examined the cytosolic pH of multidrug-resistant cells directly using a pH-sensitive dye coupled to a membrane-impermeable molecule. The dye (SNARF), covalently coupled to 10,000 MW dextran, was mechanically microinjected into the cytosol of cultured multidrug-resistant mouse NIH3T3 cells which express the human multidrug transporter. The fluorescence emission of the dye in living cells was measured using epifluorescence microscopy at different wavelengths to provide a measure of the pH of the cytosolic environment. Multidrug-resistant cells had a higher cytosolic pH than drug-sensitive normal parental cells. As the pH of the culture medium was increased, normal cells maintained their cytosolic pH below 7.0, whereas the cytosolic pH of multidrug resistant cells rose. The difference in cytosolic pH between the two cell types was more than 0.2 pH units at an external culture medium pH of 8.2. Treatment with agents that inhibit multidrug transporter-mediated efflux, such as verapamil and vinblastine, essentially eliminated the elevation of cytosolic pH, presumably because they are good substrates for the pump which overwhelm its capacity to pump other materials. These results suggest that the multidrug transporter is indirectly a proton pump, and that cells may contain an endogenous substrate or substrates for this transporter in the absence of added drugs.
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
F
F
Thiebaut
S J
SJ
Currier
J
J
Whitaker
R P
RP
Haugland
M M
MM
Gottesman
I
I
Pastan
M C
MC
Willingham
D000468:Alkalies / Q000378:metabolism*; D000818:Animals; D001578:Benzopyrans; D002460:Cell Line; D003078:Colchicine / Q000494:pharmacology; D003600:Cytosol / Q000378:metabolism*; D003911:Dextrans; D004337:Drug Carriers / Q000378:metabolism*; D004351:Drug Resistance; D005456:Fluorescent Dyes; D006863:Hydrogen-Ion Concentration; D008845:Microinjections; D014700:Verapamil / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
D000468:Alkalies; D001578:Benzopyrans; D003911:Dextrans; D004337:Drug Carriers; D005456:Fluorescent Dyes; C063917:SNARF dye; D014747:Vinblastine; D014700:Verapamil; D003078:Colchicine